Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)

• Conditions: Type II Diabetes Mellitus

• Registration Number: NCT03025919
• Lead Sponsor: Zhongda Hospital

Brief Summary

Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Detailed Description

Using the WHO criteria as the golden standard，drawing the ROC curve of 2h-UG combined with FPG, AGEsP alone or in combination with FPG，calculating the area under the ROC curve.

Study Timeline

• Study Start: 2017-01
• Study First Submitted: 2017-01-11
• Study First Submitted QC: 2017-01-16
• Study First Posted: 2017-01-20
• Status Verified: 2017-05
• Last Update Submitted: 2017-05-03
• Last Update Posted: 2017-05-08
• Primary Completion: 2017-06
• Study Completion: 2017-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

• 20~70 year old urban and rural residents;
• Volunteer to participate in this study and sign informed consent.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
area under the ROC curve	6 months	area under the ROC curve of different method of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Secondary Outcome Measures

Name	Time	Method
sensitivity and specificity of screening	6 months	Using WHO criteria as golden standard,sensitivity and specificity of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Trial Locations

Locations (1)

Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University; 🇨🇳 Nanjing, Jiangsu, China